Katz Ilan
- SEC CIK
- 0001838085
No open-market purchases or sales filed in the past year.
Current role at each company
- SABS SAB Biotherapeutics, Inc.Director, 10% Owneras of Oct 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Katz Ilan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Katz IlanDirector, 10% Owner | PPurchase | +500 | $10.11 | +$5.05K | +50.0%1.50K after | |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Katz IlanDirector, 10% Owner | PPurchase | +1.00K | $10.09 | +$10.1K | New position1.00K after |